Rose Geoffrey Beran's Form 4 filing
Pulmonx Corp (LUNG) · filed Dec 4, 2024
- Accession no.
- 0001415889-24-028319
- Filed
- Dec 4, 2024
- Trade date
- Dec 2, 2024
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 4 non-derivative transactions and 0 derivative transactions. Open-market sales total $27.1K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Rose Geoffrey BeranCIK 0001804146 | Officer (CHIEF COMMERCIAL OFFICER) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 2, 2024 | Common Stock | SSaleDisposed | −392 | $6.19 | −$2,426.48 | 295,041 | Direct | |
| Dec 2, 2024 | Common Stock | SSaleDisposed | −690 | $6.18 | −$4,264.2 | 294,351 | Direct | |
| Dec 2, 2024 | Common Stock | SSaleDisposed | −1,756 | $6.19 | −$10,869.64 | 292,595 | Direct | |
| Dec 2, 2024 | Common Stock | SSaleDisposed | −1,538 | $6.18 | −$9,504.84 | 291,057 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.